Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

RevHealth: 2017

With Change Comes Opportunity’ has always been our guiding principle,” according to executives at RevHealth. “As we’ve continued to grow, we’ve never lost sight of what this represents,” management says. “More than a decade later, it serves as a constant reminder to not only be thinking of ways to shape the market to benefit our clients’ brands, but also to be ready to capitalize on the change that exists to find innovative and impactful solutions.”

Read More »

Sandbox: 2017

According to agency leadership, 2016 marked the completion of the transition, creation and implementation of the Sandbox single agency model. “The GA Communication Group is officially history,” executives say. “The depth and hard-fought expertise of the agency’s 34-year healthcare experience was transformed in 2016 and is now surrounded by the breadth of what the Sandbox agency now offers its clients.”

Read More »

Scout Marketing: 2017

SCOUT continued its rapid growth in 2016, but simultaneously evolved and diversified, agency leaders say. “While SCOUT remains a full-service agency, its robust, integrated digital team has enabled the agency to compete successfully against pure digital agencies,” executives say. “This positions SCOUT to assume a broad role with its client partners, which lends efficiency and close coordination of communications.”

Read More »

Sentient Interactive: 2017

An award-winning, results-driven marketing agency, Sentient develops, launches, and optimizes multichannel marketing campaigns in support of direct-to-consumer and healthcare professional audiences throughout the customer lifecycle. According to management, Sentient’s goal is to help clients build enduring relationships with their target customer segments while creating measurable results for their brands.

Read More »

Sentrix Health Communications: 2017

“Anything but Typical,” the Sentrix mantra, continues to define the spirit of the agency. Leadership says Sentrix combines a creatively driven attitude with a focus on intimate client relationships.

Read More »

Solstice HealthCommunications: 2017

To some in the industry, Solstice HealthCommunications may seem like the new agency on the block, agency leaders say. They add that the agency’s team members, however, have deep roots in the healthcare sphere, and their collective talent brings clients the years of industry experience, insight, knowledge, and passion their brands deserve.

Read More »

Sound Healthcare Communications: 2017

According to agency leaders, it was quite a year for Sound in 2016. Two major launches kept the agency busy, while the addition of six new clients led to continued growth and yet another office expansion.

Read More »

Strikeforce Communications: 2017

2016 was marked by several launches for the world’s biggest blockbusters “True to its name, STRIKEFORCE marched into 2016 and seized key launch assignments for two of the world’s biggest drugs from Amgen and Gilead,” agency executives say. “By year’s end, the agency had cemented its DTC AOR status for Gilead’s entire hepatitis C portfolio, including major launches for a multi-channel Hep C Get Tested disease awareness campaign as well as the branded launch for Epclusa. STRIKEFORCE also introduced new DTC work for Amgen’s Neulasta Onpro and was tapped to handle creative duties for Imlygic.”

Read More »

Triple Threat Communications: 2017

Triple Threat Communications (TTC) kept busy in 2016. “We helped launch a new market entry that features a novel formulation technology,” TTC leadership says. “We developed corporate communications for a specialty pharma company with pipeline products. We helped new and established brands succeed on the digital front. We helped deepen field force understanding of key market issues. We launched an online behavioral science assessment tool to help marketing teams adjust their thinking and the way they work.”

Read More »

Becton Dickinson to acquire Bard for $24 billion

U.S. medical equipment supplier Becton Dickinson and Co. will acquire C. R. Bard Inc. in a $24 billion cash-and-stock deal, adding Bard’s devices to its portfolio in the high-growth sectors of oncology and surgery, both companies said.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2018 Focus: Top 50 Pharma, Company of the Year and more!


Ad Right Bottom